Home>Topics>Stocks>Dendreon Corporation

Dendreon Corporation

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

    Headlines

    Mon, 7 Jul 2014

    By PR Research : Followers of Dendreon ( DNDN ) may have noticed that since May, the ..... is a discussion for another time). Dendreon stock has now approached the upper trendline ..... click to enlarge) Option trading in DNDN has seen some accumulation of July 2

  2. What Does Dendreon Need To Succeed?

    Headlines

    Mon, 7 Jul 2014

    By Bill Maurer : I know that my coverage of biotech Dendreon ( DNDN ) has been heavily slanted towards the negative side ..... shares back from their 52-week low of $1.81. For Dendreon , there is still hope, although the picture may not

  3. Long Or Short: Cancer Cures

    Headlines

    Thu, 26 Jun 2014

    amount of attention and funding, however, the use of engineered immune cells for cancer therapeutics is far from the bleeding edge. Dendreon ( DNDN ), a company spun out of Stanford Medical School in 1992, demonstrated Complete Story »

  4. Dendreon May Still Be In Play

    Headlines

    Tue, 24 Jun 2014

    By David Runyan : Dendreon 's Stock Price Makes for Easy Pickins ..... This could well be the case for Dendreon ( DNDN ). However, a combination of recent ..... price of its shares (very similar to Dendreon 's current situation). Faced with

  5. Long Or Short - Cancer Cures

    Headlines

    Tue, 24 Jun 2014

    and funding, however, the use of engineered immune cells for cancer therapeutics is far from the bleeding edge. Dendreon ( DNDN ), a company spun out of Stanford Medical School in 1992, demonstrated engineered dendritic Complete Story »

  6. 3 Terrific Reasons To Buy Dendreon

    Headlines

    Wed, 18 Jun 2014

    By Renu Singh : Biotechnology company Dendreon ( DNDN ) is not in good health in 2014. The ..... marginally better as compared to last year. Dendreon 's cancer drug, Provenge, turned in ..... in half from the year-ago period, Dendreon 's shares fell. But, on a year-over

  7. Dendreon CEO To Shorts: Bombs Away!

    Headlines

    Wed, 11 Jun 2014

    little while ago I wrote an article here about the options for DNDN going forward. The short, short version is that they either ..... dilutive or be acquired. I concluded by writing: Owners of DNDN should realize they don't really own a share of the company

  8. Dendreon CEO Leaves: Buyout Or Bankruptcy?

    Headlines

    Mon, 9 Jun 2014

    Just a week ago, I detailed how biotech Dendreon ( DNDN ) was on the clock . The company has ..... really surprising news from the company. Dendreon CEO John Johnson announced that he was ..... June 3, 2014. Douglas G. Watson, Dendreon 's lead independent director, has been

  9. Dendreon CEO stepping down; shares +2.3% AH

    Headlines

    Mon, 9 Jun 2014

    Dendreon ( DNDN ) chairman/CEO John H. Johnson plans to step down for "personal reasons." Johnson has already resigned as chairman, and

  10. New Morningstar Analyst Report for Seattle Genetics, Inc.

    Stock Reports

    Fri, 17 Jan 2014

    in the investment community (given the recent failure of Dendreon 's pricey prostate cancer drug to live up to sales expectations ..... in the investment community following the recent failure of Dendreon 's DNDN pricey prostate cancer drug Provenge to live up to sales expectations

« Prev1234Next »
Content Partners